Cytokinetics Inc (CYTK) Company Report Nov. 03, 2022, 15:14 UTC 35 Cytokinetics Reports Third Quarter 2022 Financial Results Comment Full text
Immunic Inc (IMUX) Company Report Nov. 03, 2022, 10:19 UTC 36 New SEC Filing for Immunic Inc. (NASDAQ:IMUX) Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Nov. 03, 2022, 08:46 UTC 37 Rigel Announces Five Poster Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition Comment Full text
Journey Medical Corporation (DERM) Company Report Nov. 03, 2022, 08:00 UTC 38 Journey Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022 Comment Full text
Cellectar Biosciences Inc. (CLRB) Company Report Nov. 03, 2022, 08:00 UTC 37 New SEC Form for Cellectar Biosciences, Inc. Comment Full text
Neurocrine Biosciences Inc (NBIX) Company Report Nov. 03, 2022, 07:38 UTC 36 Neurocrine Biosciences Presents Additional Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease at HSG 2022 Comment Full text
Lannett Co Inc (LCI) Company Report Nov. 03, 2022, 07:35 UTC 35 New SEC Filing for Lannett Co Inc (NYSE:LCI) Comment Full text
Edgewise Therapeutics Inc (EWTX) Company Report Nov. 03, 2022, 07:16 UTC 34 Edgewise Therapeutics - Third Quarter 2022 Comment Full text
Veracyte Inc (VCYT) Company Report Nov. 03, 2022, 07:16 UTC 37 New Form 10-Q for Veracyte, Inc. Comment Full text
Intra-Cellular Therapies Inc (ITCI) Company Report Nov. 03, 2022, 07:13 UTC 36 New Form 10-Q for Intra-Cellular Therapies Inc. Comment Full text